Abstract
The biofabrication of bone tissues represents an attractive strategy for obtaining implants when compared with current strategies, which use allogeneic or autogenous grafts due to problems related to the availability of donors, their compatibility, and risks of disease transmission of associated diseases. This strategy allows surgical planning and the production of implants in three-dimen…